Due to their immunosuppressive properties, systemic glucocorticoids are estimated to be used by 0.5% to 3% of the population annually. Glucocorticoids are effective, but their use comes with some ...
Please provide your email address to receive an email when new articles are posted on . In a proof-of-concept study across four U.K. hospitals, Korbonits and colleagues analyzed data from 53 adults ...
Crinecerfont allows for significant glucocorticoid dose reductions in adults with classic CAH while maintaining androgen control.
Approval was based on the positive outcomes of Lifyorli’s pivotal ROSELLA trial, which enrolled 381 patients with ...
The study by Israel et al. (Sept. 27 issue) 1 of bone thinning in women with asthma did not effectively control for the critical variables of the level of physical activity and the severity of asthma.
Please provide your email address to receive an email when new articles are posted on . The 2022 EULAR recommendations for the management of rheumatoid arthritis are largely similar to the 2019 ...
When the medication dose is decreased gradually, many people with lupus who have reached clinical remission are able to effectively transition off of glucocorticoids (a type of steroid drug commonly ...
A retrospective analysis found glucocorticoid treatment to reduce comorbidities in adults with Duchenne muscular dystrophy (DMD) and assessed the relationship between anthropometric measures and ...
Up to 20% of children who experience an anaphylactic episode can have a biphasic reaction, a rebound of symptoms hours after resolution of the original episode. Although glucocorticoids have been used ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results